FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
761339BLAREGENERON PHARMACEUTICALS001VEOPOZINJECTABLE;INJECTION400MG/2ML(200MG/ML)POZELIMAB-BBFG2023-08-18PrescriptionNo
761355BLAREGENERON PHARMACEUTICALS001EYLEA HDINJECTABLE;INJECTION8MG(0.07ML;114.3MG/ML)AFLIBERCEPT2023-08-18PrescriptionNo
761181BLAREGENERON PHARMACEUTICALS001EVKEEZASOLUTION; INJECTION345MG/2.3MLEVINACUMAB-DGNB2021-02-11PrescriptionNo
002EVKEEZASOLUTION; INJECTION1200MG/8MLEVINACUMAB-DGNB2021-02-11PrescriptionNo
761169BLAREGENERON PHARMACEUTICALS001INMAZEBSOLUTION; INJECTION16.7MG/1MLATOLTIVIMAB; ODESIVIMAB; MAFTIVIMAB2020-10-14PrescriptionNo
761097BLAREGENERON PHARMACEUTICALS001LIBTAYOINJECTABLE;INTRAVENOUS350MGCEMIPLIMAB-RWLC2018-09-28PrescriptionNo
761055BLAREGENERON PHARMACEUTICALS001DUPIXENTINJECTABLE; INJECTION150MG/MLDUPILUMAB2017-03-28PrescriptionNo
125559BLAREGENERON PHARMACEUTICALS001PRALUENTINJECTABLE;INJECTION75MGALIROCUMAB2015-07-24PrescriptionNo
002PRALUENTINJECTABLE;INJECTION150MGALIROCUMAB2015-07-24PrescriptionNo
125387BLAREGENERON PHARMACEUTICALS001EYLEAINJECTABLE; INJECTION40MG/MLAFLIBERCEPT2011-11-18PrescriptionNo